Condensed Consolidated Statements of Stockholders' Equity - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive (Loss) Income
Beginning balance (in shares) at Dec. 31, 2023		50,032,873
Beginning balance at Dec. 31, 2023	$ 1,097,152	$ 5	$ 6,386,191	$ (5,290,528)	$ 1,484
Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise or vesting of equity awards (in shares)		454,756
Issuance of common stock upon exercise or vesting of equity awards	529	$ 0	529
Settlement of contingent consideration (in shares)		24,657
Settlement of contingent consideration	1,877		1,877
Issuance of common stock for asset acquisition (in shares)		328,321
Stock Issued During Period, Value, Acquisitions	15,876		15,876
Stock-based compensation expense	40,782		40,782
Total other comprehensive (loss) income	(3,035)				(3,035)
Net loss	(165,911)			(165,911)
Ending balance (in shares) at Mar. 31, 2024		50,840,607
Ending balance at Mar. 31, 2024	$ 987,270	$ 5	6,445,255	(5,456,439)	(1,551)
Beginning balance (in shares) at Dec. 31, 2024	54,365,785	54,365,785
Beginning balance at Dec. 31, 2024	$ 716,058	$ 5	6,555,416	(5,837,557)	(1,806)
Stockholders' Equity [Roll Forward]
Issuance of common stock upon exercise or vesting of equity awards (in shares)		332,461
Issuance of common stock upon exercise or vesting of equity awards	0	$ 0	0
Settlement of contingent consideration	0
Stock Issued During Period, Value, Acquisitions	939		939
Stock-based compensation expense	20,431		20,431
Total other comprehensive (loss) income	956				956
Net loss	$ (90,957)			(90,957)
Ending balance (in shares) at Mar. 31, 2025	54,698,246	54,698,246
Ending balance at Mar. 31, 2025	$ 647,427	$ 5	$ 6,576,786	$ (5,928,514)	$ (850)